Effects of antipsoriasis drugs and metabolic inhibitors on the growth of epidermal cells in culture.
D000818:Animals; D000875:Anthralin / Q000494:pharmacology; D000963:Antimetabolites / Q000494:pharmacology*; D001380:Azauridine / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D003513:Cycloheximide / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D003630:Daunorubicin / Q000494:pharmacology; D006168:Guinea Pigs; D006918:Hydroxyurea / Q000494:pharmacology; D008727:Methotrexate / Q000494:pharmacology; D009173:Mycophenolic Acid / Q000494:pharmacology; D011565:Psoriasis / Q000188:drug therapy*; D011691:Puromycin / Q000494:pharmacology; D012867:Skin / Q000166:cytology / Q000187:drug effects*
D000963:Antimetabolites; D003561:Cytarabine; D003609:Dactinomycin; D011691:Puromycin; D001380:Azauridine; D003513:Cycloheximide; D009173:Mycophenolic Acid; D000875:Anthralin; D006918:Hydroxyurea; D008727:Methotrexate; D003630:Daunorubicin